Likewise, hepatic mRNA levels of apoB100 and MTTP and serum VLDL-TG were higher in patients with steatosis (n = 51) compared to patients with NASH (n = 53), marking deterioration of VLDL assembly and export as important in the progression from steatosis to NASH [75]. This evidence concerns the gene APOB and metabolic dysfunction-associated steatohepatitis.